Cited by 453Reproductive Health and TechnologiesAssisted Reproductive Technology and Twin PregnancyReproductive Biology and Fertility

Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis

Goverde, Angelique J, McDonnell, Joseph, Vermeiden, Jan PW, Schats, Roel, Rutten, Frans FH, Schoemaker, Joop·2000·The Lancet

Abstract

Background Couples affected by idiopathic subfertility or male subfertility have an estimated spontaneous conception rate of about 2% per cycle. Although various infertility treatments are available, counselling of a couple in their choice of treatment is difficult because of the lack of consistent data from good-quality comparative studies. We compared the results of treatment with intrauterine insemination (IUI) with those of in-vitro fertilisation (IVF), and did a cost-effectiveness analysis. Methods In a prospective, randomised, parallel trial, 258 couples with idiopathic subfertility or male subfertility were treated for a maximum of six cycles of either IUI in the spontaneous cycle (IUI alone), IUI after mild ovarian hyperstimulation, or IVF. The primary endpoint was a pregnancy resulting in at least one livebirth after treatment. Cost-effectiveness based on real costs was studied by Markov chain analysis. Findings 86 couples were assigned IUI alone, 85 IUI plus ovarian hyperstimulation, and 87 IVF. Ten couples dropped out before treatment began. Although the pregnancy rate per cycle was higher in the IVF group than in the IUI groups (12.2% vs 7.4% and 8.7%, respectively; p=0.09), the cumulative pregnancy rate for IVF was not significantly better than that for IUI. Couples in the IVF group were more likely than those in the IUI groups to give up treatment before their maximum of six attempts (37 [42%] drop-outs vs 13 [15%] and 14 [16%], respectively; p Interpretation Co…

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(99)04002-7

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IVF and ICSI carry significantly increased potential cost and morbidity to the patient and offspring compared with IUI.

    “However, IVF and ICSI come with significantly increased potential cost and morbidity to the patient and offspring compared to IUI (Goverde et al., 2000).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goverde, A. J., McDonnell, J., Vermeiden, J. P., Schats, R., Rutten, F. F., & Schoemaker, J.
Affiliations
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Erasmus University Rotterdam (NL)
Corresponding author
Goverde, Angelique J
Venue
The Lancet
Publisher
Elsevier BV
Published
2000-01
Volume
355
Issue
9197
Pages
13-18
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2110055479
Cited by
453
References
26
Citations by year
2026: 3 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 11 · 2021: 19 · 2020: 13 · 2019: 14 · 2018: 12 · 2017: 18 · 2016: 19 · 2015: 14 · 2014: 12 · 2013: 24 · 2012: 16
FWCI
20.78
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
in vitro fertilization, male subfertility, cost-effectiveness, ovarian hyperstimulation, treatment discontinuation, Markov chain analysis
MeSH terms
Adult, Cost-Benefit Analysis, Female, Fertilization in Vitro, Humans, Infertility, Insemination, Artificial, Male, Markov Chains, Pregnancy, Sperm Count, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review